US equities |
MU $931.24 ▲+1.87% NVDA $217.23 ▼-1.84% SNDK $1,394.83 ▼-0.61% AMD $562.23 ▼-1.50% SPCX $148.62 ▼-2.33% INTC $95.37 ▼-2.80% AAPL $342.00 ▼-0.28% MSFT $539.44 ▲+1.08%
FinancialContent

Latest News about Melanoma

Recent news which mentions Melanoma

Cancer 2023: What’s Happening in the Combat Zone?
Tags melanoma Eli Lilly (LLY) AstraZeneca (AZN)
From Stock Gumshoe
'Spot Detective' – Check your spots this summer
Tags Research Medical Spot Detective
From PRLog
Intermountain Healthcare Experts Give the Best Ways to Keep Your Child’s Skin Safe
Tags Skin Care Sunscreen melanoma
From PRUnderground
Protecting You and Your Family from Skin Cancer This Summer
Tags Intermountain Healthcare skin cancer melanoma
From PRUnderground
Iovance Outlines Frontline Melanoma Strategy For Lifileucel / Pembrolizumab Combo Therapy
Tickers IOVA MRK
Tags Biotech Benzinga IOVA
From Benzinga
Merck's Keytruda Shows Improved Metastasis-Free Survival In Melanoma Patients
Tickers MRK
Tags Market News Phase 3 Trial News
From Benzinga
Alkermes Educates on the Challenges of Mucosal Melanoma
Tickers ALKS
Tags Alkermes Health & Healthcare melanoma
From 3BL Media: Corporate Social Responsibility, Energy and Health News
French Regulatory Authority Gives Green Signal To Phio Pharma's Melanoma Trial
Tickers PHIO
Tags PHIO Long Ideas why it's moving
From Benzinga
Merck's Keytruda Wins Eighth FDA Approval Of 2021, This Time For Adjuvant, Pediatric Melanoma Settings
Tickers MRK
Tags Biotech Benzinga General
From Benzinga
New Data Reaffirms Merck's Keytruda In Extending Survival In Melanoma Patients
Tickers BMY MRK
Tags News Phase 3 Trial Market News
From Benzinga
See Why Sonnet BioTherapeutics Stock Is Skyrocketing In Premarket Tuesday
Tickers SONN
Tags melanoma Trading Ideas Market News
From Benzinga
Alkermes Receives FDA Fast Track Status For Mucosal Melanoma Immunotherapy
Tickers ALKS
Tags General Benzinga Biotech
From Benzinga